-
-
-
-
-
-
-
Correvio Reports Full Year 2019 Financial Results
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cintas, Correvio Pharma, Exelon, and Green Dot, and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Correvio Pharma (CORV) Tops Q1 EPS by 31c, Revenues Miss
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

